PMID

Data

Article Title

Organization

Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2.

University of Michigan

Non-kinase targets of protein kinase inhibitors.

The University of Sydney

Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.

University of Manchester

Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.

Purdue University

A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.

Lanzhou University

Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).

Caprotec Bioanalytics

Synthesis of novel¿¿3 receptor ligands via an unusual Knoevenagel condensation.

Moscow State University

Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.

H. Lundbeck

Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.

Purdue University

Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.

Purdue University

Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones.

University of Manchester

Potential chemopreventive agents based on the structure of the lead compound 2-bromo-1-hydroxyphenazine, isolated from Streptomyces species, strain CNS284.

Purdue University

Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.

University of Lille

Bioactive compounds from the fern Lepisorus contortus.

Yunnan Normal University

In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).

University of Manchester and Manchester Cancer Research Center

Imidazoacridin-6-ones as novel inhibitors of the quinone oxidoreductase NQO2.

The University of Manchester and Manchester Cancer Research Center

Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.

University of Manchester and Manchester Cancer Research Center

Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists.

Takeda Chemical Industries

Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).

Institut De Chimie Pharmaceutique Albert Lespagnol

Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2).

University of Manchester

Evaluation of analogues of furan-amidines as inhibitors of NQO2.

University of Manchester

Oxindole-based intraocular pressure reducing agents.

Lomonosov Moscow State University

Differential expression of multiple somatostatin receptors in the rat cerebellum during development.

Dynamique Des Systemes Neuroendocriniens

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.

Cns-Pharmacology

Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior.

Bayer